Home
>
National Drug Code (NDC)
>
Hydrochlorothiazide
Hydrochlorothiazide - 0093-2080-01 - (Hydrochlorothiazide)
Drug Information of Hydrochlorothiazide
| Product NDC: | 0093-2080 |
| Proprietary Name: | Hydrochlorothiazide |
| Non Proprietary Name: | Hydrochlorothiazide |
| Active Ingredient(s): | 12.5 mg/1 & nbsp; Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hydrochlorothiazide
| Product NDC: | 0093-2080 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090510 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110407 |
Package Information of Hydrochlorothiazide
| Package NDC: | 0093-2080-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (0093-2080-01) |
NDC Information of Hydrochlorothiazide
| NDC Code | 0093-2080-01 |
| Proprietary Name | Hydrochlorothiazide |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0093-2080-01) |
| Product NDC | 0093-2080 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydrochlorothiazide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110407 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | HYDROCHLOROTHIAZIDE |
| Strength Number | 12.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
